
Company
Amal Therapeutics SA
Incorporated
September 2012
Headquarter
Genève
Support
Cancer vaccines
Amal Therapeutics SA, a spin-off from the University of Geneva, is developing new cancer vaccines, using with a proprietary family of vectors.

